IL159674A0 - Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences - Google Patents

Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences

Info

Publication number
IL159674A0
IL159674A0 IL15967402A IL15967402A IL159674A0 IL 159674 A0 IL159674 A0 IL 159674A0 IL 15967402 A IL15967402 A IL 15967402A IL 15967402 A IL15967402 A IL 15967402A IL 159674 A0 IL159674 A0 IL 159674A0
Authority
IL
Israel
Prior art keywords
dna sequences
detecting
methods
gene transcription
transcription regulatory
Prior art date
Application number
IL15967402A
Other languages
English (en)
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01202581A external-priority patent/EP1273666A1/en
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Publication of IL159674A0 publication Critical patent/IL159674A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL15967402A 2001-07-04 2002-06-14 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences IL159674A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01202581A EP1273666A1 (en) 2001-07-04 2001-07-04 Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US30319901P 2001-07-05 2001-07-05
PCT/NL2002/000390 WO2003004704A2 (en) 2001-07-04 2002-06-14 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US10/190,312 US7192741B2 (en) 2001-07-04 2002-07-05 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences

Publications (1)

Publication Number Publication Date
IL159674A0 true IL159674A0 (en) 2004-06-20

Family

ID=47915807

Family Applications (4)

Application Number Title Priority Date Filing Date
IL15967402A IL159674A0 (en) 2001-07-04 2002-06-14 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
IL159674A IL159674A (en) 2001-07-04 2004-01-01 DNA sequences that have the ability to regulate transcription and methods for detecting and using these sequences
IL193373A IL193373A (en) 2001-07-04 2008-08-11 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
IL193374A IL193374A (en) 2001-07-04 2008-08-11 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL159674A IL159674A (en) 2001-07-04 2004-01-01 DNA sequences that have the ability to regulate transcription and methods for detecting and using these sequences
IL193373A IL193373A (en) 2001-07-04 2008-08-11 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
IL193374A IL193374A (en) 2001-07-04 2008-08-11 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences

Country Status (22)

Country Link
US (9) US7192741B2 (no)
EP (8) EP1842919B1 (no)
JP (3) JP4500044B2 (no)
KR (2) KR100942117B1 (no)
CN (1) CN1266282C (no)
AT (8) ATE467682T1 (no)
AU (3) AU2002314629B2 (no)
BR (1) BRPI0210771B8 (no)
CA (2) CA2450020C (no)
CY (1) CY1107678T1 (no)
DE (8) DE60236331D1 (no)
DK (8) DK1806407T3 (no)
ES (8) ES2344074T3 (no)
HK (1) HK1068652A1 (no)
IL (4) IL159674A0 (no)
MX (1) MXPA03011801A (no)
NO (1) NO338477B1 (no)
NZ (1) NZ530218A (no)
PT (1) PT1600510E (no)
SG (1) SG143066A1 (no)
WO (1) WO2003004704A2 (no)
ZA (1) ZA200309599B (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60236331D1 (de) 2001-07-04 2010-06-17 Chromagenics Bv DNS-Sequenzen mit Anti-Repressor-Aktivität
WO2003106674A2 (en) * 2002-06-14 2003-12-24 Chromagenics B.V. Means and methods for regulating gene expression
CA2489475C (en) * 2002-06-14 2011-03-29 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
DK1523496T3 (da) 2002-07-18 2011-10-17 Merus B V Rekombinant fremstilling af blanding af antistoffer
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
ATE524559T1 (de) 2002-12-18 2011-09-15 Chromagenics Bv Methode zur verbesserung der proteinproduktion
DE60312039T2 (de) 2002-12-20 2007-11-08 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
ES2408582T3 (es) 2003-05-30 2013-06-21 Merus B.V. Biblioteca de Fab para la preparación de una mezcla de anticuerpos
CN102174536B (zh) 2003-10-02 2013-02-13 克鲁塞尔荷兰公司 用于重组腺病毒的包装细胞
WO2005059149A2 (en) * 2003-12-12 2005-06-30 Chromagenics B.V. Improved protein production
WO2005068622A2 (en) 2004-01-20 2005-07-28 Merus B.V. Mixtures of binding proteins
JP4805262B2 (ja) * 2004-07-08 2011-11-02 クロマジェニックス ベー ヴェー 核酸の発現を改善するための新規配列
EP1786908B1 (en) * 2004-08-18 2010-03-03 Bayer CropScience AG Plants with increased plastidic activity of r3 starch-phosphorylating enzyme
EA010863B1 (ru) 2004-11-08 2008-12-30 Хромагеникс Б.В. Отбор клеток-хозяев, экспрессирующих белок на высоких уровнях
ES2384391T3 (es) * 2004-11-08 2012-07-04 Chromagenics B.V. Selección de células hospedantes que expresan proteína a altos niveles
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) * 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
JP5098014B2 (ja) * 2004-11-18 2012-12-12 国立大学法人広島大学 遺伝子増幅により形成された反復配列から、発現抑制されているタンパク質を発現させる方法、キット、および形質転換体
US7968700B2 (en) 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof
US20080124760A1 (en) 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
CN101627123A (zh) * 2007-01-08 2010-01-13 米利波尔公司 消除基因扩增的高表达细胞系
CN102459607B (zh) 2009-06-15 2014-08-06 萨拉基尼克有限公司 新的严格的可选择的标志物
US8566596B2 (en) 2010-08-24 2013-10-22 Cisco Technology, Inc. Pre-association mechanism to provide detailed description of wireless services
CN103180443B (zh) 2010-09-01 2016-01-13 萨拉基尼克有限公司 用于增强基因表达的来自核糖体蛋白启动子的核酸片段
EP3594232A1 (en) 2012-04-20 2020-01-15 Merus N.V. Methods and means for the production of ig-like molecules
EP2869845B1 (en) 2012-07-06 2019-08-28 Genmab B.V. Dimeric protein with triple mutations
EP3470431A1 (en) 2012-09-27 2019-04-17 Merus N.V. Bispecific igg antibodies as t cell engagers
US10417380B1 (en) 2013-12-31 2019-09-17 Mckesson Corporation Systems and methods for determining and communicating a prescription benefit coverage denial to a prescriber
US10489552B2 (en) 2014-02-14 2019-11-26 Mckesson Corporation Systems and methods for determining and communicating patient incentive information to a prescriber
KR20240042540A (ko) 2014-02-28 2024-04-02 메뤼스 엔.페. ErbB-2와 ErbB-3에 결합하는 항체
JP6771385B2 (ja) 2014-02-28 2020-10-21 メルス ナムローゼ フェンノートシャップ 二重特異性抗体および医薬組成物
US10157262B1 (en) 2015-03-10 2018-12-18 Mckesson Corporation Systems and methods for determining patient financial responsibility for multiple prescription products
RS57928B1 (sr) 2015-07-10 2019-01-31 Merus Nv Antitela koja vezuju humani cd3
PL3365373T3 (pl) 2015-10-23 2021-08-23 Merus N.V. Molekuły wiążące, które hamują wzrost nowotworu
US11514137B1 (en) 2016-03-30 2022-11-29 Mckesson Corporation Alternative therapy identification system
US10999224B1 (en) 2017-02-01 2021-05-04 Mckesson Corporation Method and apparatus for parsing an electronic message and constructing multiple differently prioritized messages therefrom
CN110650752A (zh) 2017-03-31 2020-01-03 美勒斯公司 用于治疗具有NRG1融合基因的细胞的ErbB-2和ErbB3结合双特异性抗体
SG11202001050PA (en) 2017-08-09 2020-03-30 Merus Nv Antibodies that bind egfr and cmet
US10862832B1 (en) 2018-07-24 2020-12-08 Mckesson Corporation Computing system and method for automatically reversing an action indicated by an electronic message
US11043437B2 (en) 2019-01-07 2021-06-22 Applied Materials, Inc. Transparent substrate with light blocking edge exclusion zone
US11562437B1 (en) 2019-06-26 2023-01-24 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
US11636548B1 (en) 2019-06-26 2023-04-25 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
EP3772518A1 (en) 2019-08-07 2021-02-10 Merus N.V. Modified human variable domains
US20230104317A1 (en) * 2020-01-31 2023-04-06 The Board Of Trustees Of The Leland Stanford Junior University Systems and Methods to Identify Genetic Silencers and Applications Thereof
US11610240B1 (en) 2020-02-17 2023-03-21 Mckesson Corporation Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction
AR122132A1 (es) 2020-05-21 2022-08-17 Merus Nv Métodos y medios para producción de moléculas tipo ig
US11587657B2 (en) 2020-09-04 2023-02-21 Mckesson Corporation Method, apparatus, and computer program product for performing an alternative evaluation procedure in response to an electronic message
CN113539357B (zh) * 2021-06-10 2024-04-30 阿里巴巴达摩院(杭州)科技有限公司 基因检测方法、模型训练方法、装置、设备及系统

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US719271A (en) * 1902-01-13 1903-01-27 Solomon P Smith Furnace.
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5972605A (en) * 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
WO1996030522A1 (fr) * 1995-03-24 1996-10-03 Shionogi & Co., Ltd. Molecule d'adn relative a la suppression d'une expression genique et nouvelle proteine
DE19539493A1 (de) * 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6037525A (en) * 1996-08-01 2000-03-14 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
CN100365127C (zh) 1998-07-21 2008-01-30 密理博公司 具有遍在染色质开放表达元件(ucoe)的聚核苷酸
ATE370247T1 (de) 1998-08-14 2007-09-15 Chromagenics Bv Dns sequenz, verfahren für dessen nachweis und herstellung und ihre benutzung
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
WO2000023606A1 (en) 1998-10-22 2000-04-27 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
NZ529329A (en) * 1999-08-25 2005-06-24 Immunex Corp Compositions and methods for improved cell culture
US6586205B1 (en) 2000-02-11 2003-07-01 Millennium Pharmaceuticals, Inc. 43239 a novel GPCR-like molecule and uses thereof
US20030166042A1 (en) 2000-02-11 2003-09-04 Millennium Pharmaceuticals, Inc. Novel seven-transmembrane proteins/G-protein coupled receptors
EP1430124B1 (en) 2000-09-20 2013-11-06 EMD Millipore Corporation Artificial ubiquitous chromatin opening elements (ucoe)
DE60236331D1 (de) 2001-07-04 2010-06-17 Chromagenics Bv DNS-Sequenzen mit Anti-Repressor-Aktivität
EP1273666A1 (en) 2001-07-04 2003-01-08 Chromagenics B.V. Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
CA2489475C (en) * 2002-06-14 2011-03-29 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
WO2003106674A2 (en) 2002-06-14 2003-12-24 Chromagenics B.V. Means and methods for regulating gene expression
ATE524559T1 (de) 2002-12-18 2011-09-15 Chromagenics Bv Methode zur verbesserung der proteinproduktion
DE60312039T2 (de) 2002-12-20 2007-11-08 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können

Also Published As

Publication number Publication date
US7192741B2 (en) 2007-03-20
EP1829971A3 (en) 2008-06-04
DK1808488T3 (da) 2010-10-18
ATE466944T1 (de) 2010-05-15
US7951586B2 (en) 2011-05-31
EP1845162A1 (en) 2007-10-17
KR20090037485A (ko) 2009-04-15
ATE466942T1 (de) 2010-05-15
AU2011202193B2 (en) 2011-09-29
EP1845162B1 (en) 2010-05-05
DK1845162T3 (da) 2010-08-16
US7736870B2 (en) 2010-06-15
DE60236379D1 (de) 2010-06-24
AU2002314629B2 (en) 2007-08-30
ATE466943T1 (de) 2010-05-15
DE60236332D1 (de) 2010-06-17
JP2004533262A (ja) 2004-11-04
US20070128717A1 (en) 2007-06-07
BRPI0210771B1 (pt) 2015-12-22
US20070026499A1 (en) 2007-02-01
DK1806407T3 (da) 2010-08-16
JP2010131025A (ja) 2010-06-17
DE60219221D1 (de) 2007-05-10
EP1600510A2 (en) 2005-11-30
PT1600510E (pt) 2007-06-25
ES2344070T3 (es) 2010-08-17
DE60236331D1 (de) 2010-06-17
DK1404872T3 (da) 2007-02-19
ATE467682T1 (de) 2010-05-15
EP1404872A2 (en) 2004-04-07
HK1068652A1 (en) 2005-04-29
CA2812799A1 (en) 2003-01-16
KR100942116B1 (ko) 2010-02-12
EP1600510B1 (en) 2007-03-28
US20070031934A1 (en) 2007-02-08
JP5014444B2 (ja) 2012-08-29
DE60236334D1 (de) 2010-06-17
CA2450020C (en) 2013-08-13
ATE358183T1 (de) 2007-04-15
BR0210771A (pt) 2004-07-13
EP1808488A2 (en) 2007-07-18
DE60219221T2 (de) 2008-01-03
SG143066A1 (en) 2008-06-27
CY1107678T1 (el) 2013-04-18
EP1404872B1 (en) 2006-10-18
DK1829972T3 (da) 2010-09-13
BRPI0210771B8 (pt) 2021-05-25
KR20090037960A (ko) 2009-04-16
EP1829971A1 (en) 2007-09-05
EP1842919B1 (en) 2010-05-05
EP1806407B1 (en) 2010-05-05
EP1808488B1 (en) 2010-07-14
CA2450020A1 (en) 2003-01-16
US7655441B2 (en) 2010-02-02
ES2348174T3 (es) 2010-11-30
CN1266282C (zh) 2006-07-26
ES2344071T3 (es) 2010-08-17
ES2285630T3 (es) 2007-11-16
EP1842919A1 (en) 2007-10-10
ES2344072T3 (es) 2010-08-17
DE60237048D1 (de) 2010-08-26
WO2003004704A3 (en) 2003-10-16
US7736868B2 (en) 2010-06-15
ZA200309599B (en) 2006-05-31
JP4500044B2 (ja) 2010-07-14
KR100942117B1 (ko) 2010-02-12
US7749733B2 (en) 2010-07-06
EP1806407A3 (en) 2008-06-04
AU2007234619B2 (en) 2011-06-02
US20070031936A1 (en) 2007-02-08
DK1842919T3 (da) 2010-08-16
DE60215502D1 (de) 2006-11-30
AU2007234619A1 (en) 2007-12-13
ATE343004T1 (de) 2006-11-15
MXPA03011801A (es) 2005-03-07
EP1829972A3 (en) 2007-10-24
NZ530218A (en) 2005-09-30
US20070031933A1 (en) 2007-02-08
ES2344074T3 (es) 2010-08-17
DK1829971T3 (da) 2010-08-16
JP2010131024A (ja) 2010-06-17
EP1806407A2 (en) 2007-07-11
EP1829971B1 (en) 2010-05-05
ES2274045T3 (es) 2007-05-16
US7736869B2 (en) 2010-06-15
EP1808488A3 (en) 2007-11-14
US7659094B2 (en) 2010-02-09
WO2003004704A2 (en) 2003-01-16
IL159674A (en) 2009-02-11
US20070026498A1 (en) 2007-02-01
EP1829972B1 (en) 2010-05-12
DE60215502T2 (de) 2007-08-30
NO338477B1 (no) 2016-08-22
US20030199468A1 (en) 2003-10-23
CA2812799C (en) 2016-01-26
ES2344073T3 (es) 2010-08-17
IL193374A (en) 2010-12-30
DK1600510T3 (da) 2007-06-25
NO20040011L (no) 2004-03-03
ATE466941T1 (de) 2010-05-15
US7662591B2 (en) 2010-02-16
US20070031935A1 (en) 2007-02-08
AU2011202193A1 (en) 2011-06-02
CN1524128A (zh) 2004-08-25
EP1600510A3 (en) 2006-02-22
ATE474053T1 (de) 2010-07-15
DE60236333D1 (de) 2010-06-17
EP1829972A2 (en) 2007-09-05
IL193373A (en) 2010-12-30
US20070037256A1 (en) 2007-02-15
JP5014443B2 (ja) 2012-08-29

Similar Documents

Publication Publication Date Title
IL193374A (en) Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
DE60039037D1 (de) Methode zur direkten sequenzierung von nukleinsäuren
UA96421C2 (ru) Нуклеотидная последовательность, кодирующая инсектицидный белок
WO2003048319A3 (en) Nucleotide sequences encoding proteins conferring abiotic stress tolerance in plants
ATE533837T1 (de) Microginin-produzierende proteine und nukleinsäuren, einen microginin gen-cluster kodierend, sowie methoden zur herstellung von microgininen
FR2883298B1 (fr) Fragments d'acides nucleiques et methode de detection specifique par identification moleculaire de differentes especes de bacteries du genre acinetobacter
WO2004089982A3 (en) April variants and methods thereof
DE60036645D1 (de) Methoden zur identifizierung evolutionär signifikanter änderungen in polynukleotid- und polypeptidsequenzen in domestizierten pflanzen und tieren
DE602004019696D1 (de) Die multiple resistenz von pflanzen gegen phytopathogene und schädlinge induzierende proteine
TH71671A (th) วิธีการสำหรับการผลิตกรดแอล-กลูตามิก
DE50203158D1 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose
DE60303257D1 (de) Substanzen, Sequenzen und Methoden zur Identifizierung epidemischer Methicillin-resistenter Staphylococcus aureus Stämme

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed